Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance

被引:126
作者
Buccafusco, JJ [1 ]
Letchworth, SR
Bencherif, M
Lippiello, PM
机构
[1] Med Coll Georgia, Alzheimers Res Ctr, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA
[2] Dept Vet Affairs Med Ctr, Augusta, GA 30904 USA
[3] Targacept, Winston Salem, NC 27101 USA
关键词
D O I
10.1016/j.tips.2005.05.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Agonists of nicotinic acetylcholine receptors (nAChRs) produce long-lasting cognitive efyfects in animal models and humans. The duration of these cognitive effects can outlast the presence of the agonists in the system, and the persistence of cognitive enhancement is increased further by repeated exposure. The basis for this discrepancy appears be the cellular and systemic mechanisms of learning and memory. Agonists of nAChRs induce long-term potentiation (LTP), which is a strengthening of synaptic connections that is associated with learning and memory formation. Some of the cellular effects of nAChR agonists overlap with the known cellular mechanisms of LTP, including longlasting increases in intracellular concentrations of Ca2+, activation of second-messenger systems and transcription factors, elevated levels of gene products and enhanced neurotransmitter release. A better understanding of this phenomenon might shed new light on the role of nAChR systems in memory formation and retrieval.
引用
收藏
页码:352 / 360
页数:9
相关论文
共 90 条
[1]   Relationship between up regulation of nicotine binding sites in rat brain and delayed cognitive enhancement observed after chronic or acute nicotinic receptor stimulation [J].
Abdulla, FA ;
Bradbury, E ;
Calaminici, MR ;
Lippiello, PM ;
Wonnacott, S ;
Gray, JA ;
Sinden, JD .
PSYCHOPHARMACOLOGY, 1996, 124 (04) :323-331
[2]   Participation of hippocampal nicotinic receptors in acquisition, consolidation and retrieval of memory for one trial inhibitory avoidance in rats [J].
Barros, DM ;
Ramirez, MR ;
Dos Reis, EA ;
Izquierdo, I .
NEUROSCIENCE, 2004, 126 (03) :651-656
[3]  
Bartolomeo AC, 2000, J PHARMACOL EXP THER, V292, P584
[4]  
Belluardo N, 1999, MOL BRAIN RES, V74, P98
[5]   Acute intermittent nicotine treatment produces regional increases of basic fibroblast growth factor messenger RNA and protein in the tel- and diencephalon of the rat [J].
Belluardo, N ;
Blum, M ;
Mudo, G ;
Andbjer, B ;
Fuxe, K .
NEUROSCIENCE, 1998, 83 (03) :723-740
[6]  
BENCHERIF M, 1995, J PHARMACOL EXP THER, V275, P987
[7]   EVIDENCE THAT TOBACCO SMOKING INCREASES THE DENSITY OF (-)-[H-3]NICOTINE BINDING-SITES IN HUMAN-BRAIN [J].
BENWELL, MEM ;
BALFOUR, DJK ;
ANDERSON, JM .
JOURNAL OF NEUROCHEMISTRY, 1988, 50 (04) :1243-1247
[8]   LONG-LASTING POTENTIATION OF SYNAPTIC TRANSMISSION IN DENTATE AREA OF ANESTHETIZED RABBIT FOLLOWING STIMULATION OF PERFORANT PATH [J].
BLISS, TVP ;
LOMO, T .
JOURNAL OF PHYSIOLOGY-LONDON, 1973, 232 (02) :331-356
[9]   In vitro and in vivo characterization of TC-1827, a novel brain α4β2 nicotinic receptor agonist with pro-cognitive activity [J].
Bohme, GA ;
Letchworth, SR ;
Piot-Grosjean, O ;
Gatto, GJ ;
Obinu, MC ;
Caldwell, WS ;
Laville, M ;
Brunel, P ;
Pellerin, R ;
Leconte, JP ;
Genevois-Borella, A ;
Dubedat, P ;
Mazadier, M ;
Pradier, L ;
Bencherif, M ;
Benavides, J .
DRUG DEVELOPMENT RESEARCH, 2004, 62 (01) :26-40
[10]  
Bontempi B, 2001, J PHARMACOL EXP THER, V299, P297